In humans, mutations to LAMA2 can lead to congenital muscular dystrophy characterised by muscle weakness, respiratory problems and delayed motor development (El Kadiri et al. 2021; Tan et al. 2021). Here, LAMA2 is linked to congenital muscular dystrophy.